GSK (NYSE: GSK) 30-day option implied volatility is at 28; compared to its 52-week range of 20 to 35. Call put ratio 1 call to 3.5 puts with a focus on June 50 puts into talks to buy Nuvalent (NUVL) for $9B-$10B, FT says.